Views

CrossRef citations to date

Altmetric

COMMENTARY

Clinical Outcomes in Breast Cancer: Innovations and Ideas Commentary on “Expression of CDK13 was Associated with Clinical Outcomes and Expression of HIF-1 and Beclin1 in Breast Cancer Patients”

Giuseppe Diluisoa Department of Medicine, Surgery and Neuroscience, Unit of Plastic Surgery, University of Siena, Siena, Italy;

, MD,

Roberto Cuomoa Department of Medicine, Surgery and Neuroscience, Unit of Plastic Surgery, University of Siena, Siena, Italy; Correspondence[email protected]

, MD,

Francesco Volantia Department of Medicine, Surgery and Neuroscience, Unit of Plastic Surgery, University of Siena, Siena, Italy;

, MD,

Giuseppe Nisia Department of Medicine, Surgery and Neuroscience, Unit of Plastic Surgery, University of Siena, Siena, Italy;

, MD,

Margherita Aglianòb Department of Medicine, Surgery and Neuroscience, University of Siena, Siena, Italy;

, MD,

Francesco Ruben Giardinoa Department of Medicine, Surgery and Neuroscience, Unit of Plastic Surgery, University of Siena, Siena, Italy;

, MD,

Luigi Loscoc Department of Translational Research and New Technologies in Medicine and Surgery, Plastic Surgery Unit, University of Pisa, Pisa, Italy

https://orcid.org/0000-0001-9105-1839

, MD

Luca Grimaldia Department of Medicine, Surgery and Neuroscience, Unit of Plastic Surgery, University of Siena, Siena, Italy;

, MD show all

"Clinical Outcomes in Breast Cancer: Innovations and Ideas Commentary on “Expression of CDK13 was Associated with Clinical Outcomes and Expression of HIF-1 and Beclin1 in Breast Cancer Patients”." Journal of Investigative Surgery, 35(2), pp. 448–449

Disclosure statement

No potential conflict of interest was reported by the author(s).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Clinical Outcomes in Breast Cancer: Innovations and Ideas Commentary on “Expression of CDK13 was Associated with Clinical Outcomes and Expression of HIF-1 and Beclin1 in Breast Cancer Patients”

Information for

Open access

Opportunities

Help and information

Clinical Outcomes in Breast Cancer: Innovations and Ideas Commentary on “Expression of CDK13 was Associated with Clinical Outcomes and Expression of HIF-1 and Beclin1 in Breast Cancer Patients”

Disclosure statement

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Your download is now in progress and you may close this window

Login or register to access this feature